J&J In-Licenses Twice in Diabetes

By Staff Editor

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 2 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1359     ISSN: 1756-7874

Section: Licensing



Johnson & Johnson has signalled its desire to build a therapeutic franchise in diabetes by signing two licensing deals via its Ortho-McNeil-Janssen Pharmaceuticals subsidiary...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details